Dren Bio raises $350m for dibotatug clinical development

​

Dren Bio has secured $350m in an oversubscribed private financing round to advance its primary investigational therapy, dibotatug, through late-stage clinical evaluation, regulatory submission, and potential commercialisation.

The post Dren Bio raises $350m for dibotatug clinical development appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.